These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 24437159)

  • 1. [Therapeutic strategy for diffuse toxic goiter].
    Bebezov BKh; Nuraliev MA; Kakchekeeva TT; Salieva BR; Chazymov RM
    Klin Med (Mosk); 2013; 91(9):61-7. PubMed ID: 24437159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of diffuse toxic goiter].
    Balabolkin MI
    Probl Endokrinol (Mosk); 1986; 32(3):45-8. PubMed ID: 3755532
    [No Abstract]   [Full Text] [Related]  

  • 3. [The diagnosis and treatment of diffuse toxic goiter in the USSR in 1991].
    Dedov II; Gerasimov GA; Iudenich ON; Zhdanova ES; Iur'eva NP; Korostyshevskaia IL; Mushinskaia KV
    Ter Arkh; 1992; 64(10):58-62. PubMed ID: 1283037
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical Inquiry. Medication vs radioablation for Graves' disease: how do they compare?
    Ford J; Neher JO; Safranek S
    J Fam Pract; 2012 May; 61(5):294-5. PubMed ID: 22577634
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of patients with toxic diffuse goiter].
    Spesivtseva VG
    Klin Med (Mosk); 1983 Oct; 61(10):118-23. PubMed ID: 6417398
    [No Abstract]   [Full Text] [Related]  

  • 6. Relevance of cause of hyperthyroidism in determining its management.
    Veneman TF; Weymer M; Tjabbes T; van Haeften TW
    Neth J Med; 1989 Dec; 35(5-6):303-8. PubMed ID: 2635287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Main trends and controversies in treatment of patients with diffuse toxic goiter and thyroid gland cancer].
    Romanchishen AF; Vabalaĭte KV
    Vestn Khir Im I I Grek; 2011; 170(3):58-63. PubMed ID: 21848241
    [No Abstract]   [Full Text] [Related]  

  • 8. [Surgical treatment of recurrent goiter].
    Sedov VM; Sedletskiĭ IuI; Belianina EO
    Vestn Khir Im I I Grek; 1999; 158(5):53-6. PubMed ID: 10645583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Management of multinodular non-toxic goiter].
    Petrányi G
    Orv Hetil; 1994 Dec; 135(51):2851-2. PubMed ID: 7838520
    [No Abstract]   [Full Text] [Related]  

  • 10. [Radioiodine versus surgery in the treatment of Graves' hyperthyroidism].
    Jukić T; Stanicić J; Petric V; Kusić Z
    Lijec Vjesn; 2010; 132(11-12):355-60. PubMed ID: 21294325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current approaches to the treatment of diffuse toxic goiter].
    Balabolkin MI
    Ter Arkh; 1995; 67(10):15-8. PubMed ID: 8779095
    [No Abstract]   [Full Text] [Related]  

  • 12. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements.
    Berg GE; Michanek AM; Holmberg EC; Fink M
    J Nucl Med; 1996 Feb; 37(2):228-32. PubMed ID: 8667049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Radioiodine therapy of recurrent hyperthyroidism in patients previously treated for diffuse toxic goiter with subtotal surgery].
    Vestergaard H; Laurberg P
    Ugeskr Laeger; 1993 Aug; 155(31):2403-5. PubMed ID: 8346592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The vanishing surgical treatment of Graves' disease: review of current literature and experience with 50 patients.
    Argov S; Duek D
    Curr Surg; 1982; 39(3):158-62. PubMed ID: 7047083
    [No Abstract]   [Full Text] [Related]  

  • 15. Differences and similarities in the treatment of diffuse goiter in Europe and the United States.
    Wartofsky L; Glinoer D; Solomon B; Lagasse R
    Exp Clin Endocrinol; 1991 May; 97(2-3):243-51. PubMed ID: 1717298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness of the therapeutic use of 125I in diffuse toxic goiter].
    Livergant IuE; Chebotareva ED; Polishchuk LN
    Med Radiol (Mosk); 1977 Jan; 22(1):39-44. PubMed ID: 577294
    [No Abstract]   [Full Text] [Related]  

  • 17. Is subtotal thyroidectomy a cost-effective treatment for Graves disease? A cost-effectiveness analysis of the medical and surgical treatment options.
    Zanocco K; Heller M; Elaraj D; Sturgeon C
    Surgery; 2012 Aug; 152(2):164-72. PubMed ID: 22503512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Autoimmune reactions in diffuse toxic goiter after treatment with radioactive iodine].
    Mazepa MA; Parashchak AP; Tomashivskaia LV; Rypan VS; Ivano-Frankovsk
    Med Radiol (Mosk); 1976 Feb; 21(2):72-3. PubMed ID: 946323
    [No Abstract]   [Full Text] [Related]  

  • 19. Post-therapeutic thyroid reserve. Thyroid reserve in euthyroid patients after ablative therapy for diffuse toxic goiter.
    Prendergast JJ; Miller JM
    Henry Ford Hosp Med J; 1970; 18(1):3-10. PubMed ID: 5467196
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of Graves' hyperthyroidism.
    Orgiazzi J
    Endocrinol Metab Clin North Am; 1987 Jun; 16(2):365-89. PubMed ID: 2446867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.